TY  - GEN
AU  - Guilhot,F
AU  - Lamagnère,J P
AU  - Harousseau,J L
AU  - Tilly,H
AU  - Casassus,P
AU  - Ifrah,N
AU  - Rochant,H
AU  - Bauters,F
AU  - Dine,G
AU  - Tanzer,J
TI  - A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results
SN  - 0959-8049
PY  - 1992///0417
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cytarabine
KW  - administration & dosage
KW  - Female
KW  - Humans
KW  - Hydroxyurea
KW  - Interferon Type I
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Recombinant Proteins
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/0277-5379(91)90561-q
ER  -